Capital Fund Management (CFM)
EDIT icon

Capital Fund Management (CFM)’s Editas Medicine EDIT Stock Holding History

Capital Fund Management (CFM)’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-24,100
Closed -$285K – 1467
2022
Q2 		$285K Sell
24,100
-31,600
-57% -$423K ﹤0.01% 1341
2022
Q1 		$1.06M Sell
55,700
-26,000
-32% -$483K 0.01% 1139
2021
Q4 		$2.17M Buy
81,700
+66,200
+427% +$2.28M 0.02% 1002
2021
Q3 		$637K Buy
+15,500
New +$849K ﹤0.01% 1313
2018
Q2 		– Sell
-13,100
Closed -$434K – 2051
2018
Q1 		$434K Buy
+13,100
New +$467K ﹤0.01% 1498

Other funds holding EDIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Fund Management (CFM)'s EDIT Position: Q3 2023 in Review

Capital Fund Management (CFM) sold out of Editas Medicine (EDIT) in Q3 2023, closing a stake of 158,647 shares — an estimated $1.31M sold.

Capital Fund Management (CFM) first reported a position in EDIT in Q3 2018 and held it in 13 quarters. The position peaked at $6.99M in Q1 2022. 220 funds tracked by Wall St. Rank hold EDIT as of Q3 2023.

  • Capital Fund Management (CFM) reported no remaining Editas Medicine position as of Q3 2023 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 158,647 Editas Medicine shares in Q3 2023, an estimated $1.31M.
  • Capital Fund Management (CFM) first reported a position in Editas Medicine in Q3 2018 and held it in 13 quarters.
  • Capital Fund Management (CFM)'s Editas Medicine position peaked at $6.99M in Q1 2022.
  • 220 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2023.

Based on Capital Fund Management (CFM)'s 13F filing for Q3 2023, filed 14 Nov 2023.